Cochrane have made important changes to allow the two versions of RevMan - RevMan Web (online) and RevMan 5 (desktop) to work more closely together. These are important changes that will affect all authors.
A final version of RevMan 5 (RevMan 5.4) is now available for download. RevMan 5.4 looks and feels like RevMan 5.3 but will be more closely connected to RevMan Web.
Please download RevMan 5.4 now if you wish to continue to work on your Cochrane Reviews in desktop RevMan. Cochrane will be switching off RevMan 5.3 in mid-August and you will not be able to edit your reviews.
Cochrane has recently announced an udpated and more rigorous conflict of interest policy with the anticipated launch on 1 October 2020. The updated policy will apply to all newly registered titles and updates that begin after the launch date, and will not apply to ongoing projects registered before the launch.
Please read it here and contact us with any questions you may have.
Update: Cochrane have now produced a one page quick guidance for authors which explains the key points of the CoI policy for Cochrane Library Content.
Interested in writing a Cochrane review and an expert in cardiology? - Consider these vacant titles:
Proposals closing on 31 December 2020 (deadline extended):
Remote monitoring of Implantable Cardiac Defibrillators for prevention of cardiovascular outcomes
Alcohol consumption and cardiovascular disease**
**After reviewing the scope of this title, we invite proposals for three narrower topics as follows:
Interventions for alcohol cessation in people with heart failure
Interventions for alcohol cessation in people with atrial fibrillation
Interventions for alcohol cessation in people with ischemic heart disease
Colchicine for the primary prevention of cardiovascular events (supersedes our existing reviewthat is split into two new reviews, one for primary prevention and one for secondary prevention)